The drug of abuse testing market size is poised to grow by $ 9.15billion by 2032 from $ 4.90 Billion in 2022, exhibiting a CAGR of 6.5% during the forecast period 2023-2032.

Key Takeaway

• By drug type, the cannabis/marijuana segment hit highest revenue share of over 27% in 2022.
• In 2022, North America region captured revenue share of over 39.6%.
• By product, analyzers segment is expected to grow at a 5.7% CAGR from 2023 to 2032.
• North America drug of abuse testing market is expected to reach at a CAGR of 5.5% iover the forecast period 2023 to 2032. 

Get a Sample: https://www.precedenceresearch.com/sample/1313

COVID-19 Impact

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the electric vehicle fuel cell market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Major companies operating in this area

• Danaher Corporation
• LabCorp
• Abbott Laboratories
• Quest Diagnostics, Inc.
• Cordant Health Solutions
• DrugScan
• Legacy Medical Services
• Mayo Clinic Laboratories
• LGC Group
• Precision Diagnostics

Market Segmentation

By Drug Type

• Alcohol
• Cocaine
• Marijuana/Cannabis
• LSD
• Opioids
• Others

By Sample Type

• Urine
• Saliva
• Blood
• Hair
• Breath
• Others

By Product

• Equipment
  • Immunoassay Analyzers
  • Chromatography Instruments
  • Breath Analyzers
• Consumables
  • Rapid Test Kits
  • Reagents
  • Others

By Application

• Medical Screening
• Monitoring Pain Management
• Forensic & Legal Information
• Employment Drug Testing
• Sports & Athletics Testing

By End User

• Workplaces
• Criminal Justice Systems
• Hospitals
• Research Labs

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Major highlights of Report:

• Figures related to sales volume, market remuneration, and segmental shares
• Featuring market dynamics
• Growth prospects and expansion graph
• PROCON study of direct & indirect sales channels
• Profiles of prominent traders, dealer, and distributors in the industry

Geographical landscape: North America, Europe, Asia-Pacific, South America, Middle East and Africa

• Industry forecasts based on region and at country level
• Data about sales volume recorded, industry share held, and profit margins amassed
• Overall remuneration and estimated growth rate for each regional market

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.

Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Drug of Abuse Testing Market, By Drug

7.1. Drug of Abuse Testing Market, by Drug Type, 2021-2030

7.1.1. Alcohol

7.1.1.1. Market Revenue and Forecast (2019-2030)

7.1.2. Cocaine

7.1.2.1. Market Revenue and Forecast (2019-2030)

7.1.3. Marijuana/Cannabis

7.1.3.1. Market Revenue and Forecast (2019-2030)

7.1.4. LSD

7.1.4.1. Market Revenue and Forecast (2019-2030)

7.1.5. Opioids

7.1.5.1. Market Revenue and Forecast (2019-2030)

7.1.6. Others

7.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Drug of Abuse Testing Market, By End User

8.1. Drug of Abuse Testing Market, by End User, 2021-2030

8.1.1. Workplaces

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Criminal Justice Systems

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Hospitals

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Research Labs

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Drug of Abuse Testing Market, By Sample 

9.1. Drug of Abuse Testing Market, by Sample, 2021-2030

9.1.1. Urine

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Saliva

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Blood

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Drug of Abuse Testing Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Drug (2019-2030)

10.1.2. Market Revenue and Forecast, by End User (2019-2030)

10.1.3. Market Revenue and Forecast, by Sample (2019-2030)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.1.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.1.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.1.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.1.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.6.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.6.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.7.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.7.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.6.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.6.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.7.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.7.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.6.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.6.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.7.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.7.3. Market Revenue and Forecast, by Sample (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.5.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.5.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.5.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.5.5.3. Market Revenue and Forecast, by Sample (2019-2030)

Chapter 11. Company Profiles

11.1. Danaher Corporation

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. LabCorp

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Abbott Laboratories

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Quest Diagnostics, Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Cordant Health Solutions

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. DrugScan

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Legacy Medical Services

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Mayo Clinic Laboratories

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. LGC Group

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Precision Diagnostics

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: [email protected]

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com